semaglutide for quitting smoking Association of With Tobacco Use Disorder in Patients With Type 2 Diabetes: Target Trial Emulation Using Real-World Data: Annals of Internal Medicine: Vol 177, No 8 | Robert Gabbay MD, PhD GLP-1 Medications and Quitting Smoking

Qualitative studies of trial participants reveal early-onset appetite changes, with 86% of treated participants reporting alterations in eating behaviors within the first 8 weeks of treatment

Appetite & energy balance Through GLP-1 and GIP signaling, Retatrutide reduces drive to feed while supporting better energy regulation

Neuroscience 298 , 1225 (2015)

Wellbutrins Advantage Wellbutrins lower risk of sexual dysfunction makes it an attractive alternative

Perimenopause. The Menopause Society , The Menopause Society, 2025, Burger, Henry G., et al

Sleep disorders, including obstructive sleep apnea (common in obesity), insomnia, and insufficient sleep duration, significantly impair concentration, memory, and mental clarity